You're contacting media contact of this press release

Title: Cygenex Debuts CyPHR AI Engine, Bridging Genetic Intelligence and Real-Time Education

United States, 30th Mar 2026 - Cygenex, a leader in precision medicine and pharmacogenomic risk optimization, today announced the launch of CyPHR™ (Cygenex Precision Health Response) an AI-powered health assistant designed to translate an individual’s genetic blueprint into actionable, real-time clinical guidance.CyPHR represents a major advancement in the application of pharmacogenomics, bridging the gap between genetic insight and everyday healthcare decisions. By integrating DNA data, CyPHR, empowering both patients and providers to move from reactive care to proactive, precision-driven intervention.Eliminating Trial-and-Error MedicineTraditional prescribing models rely heavily on trial and error often resulting in ineffective therapies, adverse drug reactions, and avoidable healthcare costs. Cypher is an AI tool for educational purposes and is designed to help people better understand the science behind their pharmacogenomic results.CyPHR replaces this outdated approach with DNA-driven precision, by educating individuals on their genetic profile. By cross-referencing genetic data with current medications, CyPHR educates the individual on potential risks and adverse interactions.“For decades, healthcare has operated without visibility into one of the most critical variables individual biology,” said Charles Clark, CEO. “CyPHR changes that. It transforms static genetic data into a dynamic, real-time education tool that provides individuals insights into their path to better health.”A 24/7 Digital Health Co-PilotCyPHR functions as a continuous, AI-powered health companion providing users with ongoing guidance. According to the product overview CyPHR’s Precision Health Assistant performs the following:Synthesize genetic, lifestyle, and health data into clear, actio...

This press release is issued by King Newswire